BIGH3 Promotes Osteolytic Lesions in Renal Cell Carcinoma Bone Metastasis by Inhibiting Osteoblast Differentiation
Authors:
Open Access
- 27 November 2017
- Vol. 20 (1) , 32-43
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Cabozantinib Inhibits Growth of Androgen-Sensitive and Castration-Resistant Prostate Cancer and Affects Bone RemodelingPLOS ONE, 2013
- BMP4 Promotes Prostate Tumor Growth in Bone through OsteogenesisCancer Research, 2011
- Cellular and Molecular Mechanisms of Bone RemodelingJournal of Biological Chemistry, 2010
- Src family kinase/abl inhibitor dasatinib suppresses proliferation and enhances differentiation of osteoblastsOncogene, 2010
- Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell CarcinomaClinical Cancer Research, 2009
- Cadherin-11 Promotes the Metastasis of Prostate Cancer Cells to BoneMolecular Cancer Research, 2008
- A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formationOncogene, 2008
- Two novel VHL targets, TGFBI (BIGH3) and its transactivator KLF10, are up-regulated in renal clear cell carcinoma and other tumorsBiochemical and Biophysical Research Communications, 2008
- Gene expression profile of human bone marrow stromal cells determined by restriction fragment differential display analysisJournal of Cellular Biochemistry, 2004
- A New Member of Tumor Necrosis Factor Ligand Family, ODF/OPGL/TRANCE/RANKL, Regulates Osteoclast Differentiation and FunctionBiochemical and Biophysical Research Communications, 1999